📰 Given Amarin News
Given Amarin News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Given Amarin. Real-time updates on events, politics, business and more.
March 10, 2024
Amarin (NASDAQ:AMRN – Get Free Report) and Ono Pharmaceutical (OTCMKTS:OPHLY – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends and valuation. Valuation and Earnings This table compares Amarin and Ono […]
October 22, 2023
Amarin (NASDAQ:AMRN – Get Free Report) and Roche (OTCMKTS:RHHBY – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, profitability, earnings, dividends and valuation. Volatility and Risk Amarin has a beta of 1.87, indicating […]
October 15, 2023
Amarin (NASDAQ:AMRN – Get Free Report) and Roche (OTCMKTS:RHHBY – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, dividends, earnings, valuation and risk. Valuation and Earnings This table compares Amarin and Roche’s top-line […]
June 20, 2023
Sanofi (OTCMKTS:SNYNF – Get Rating) and Amarin (NASDAQ:AMRN – Get Rating) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings. Insider and Institutional Ownership 30.1% of Sanofi shares are owned by institutional […]
June 15, 2023
Amarin (NASDAQ:AMRN – Get Rating) and Sanofi (OTCMKTS:SNYNF – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership. Earnings & Valuation This table compares Amarin and Sanofi’s top-line revenue, earnings […]
April 13, 2023
NeuroBo Pharmaceuticals (NASDAQ:NRBO – Get Rating) and Amarin (NASDAQ:AMRN – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, risk, profitability and valuation. Earnings & Valuation This table compares NeuroBo Pharmaceuticals and Amarin’s […]
April 10, 2023
Amarin (NASDAQ:AMRN – Get Rating) and Aeterna Zentaris (NASDAQ:AEZS – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, institutional ownership, dividends, valuation and risk. Profitability This table compares Amarin and Aeterna Zentaris’ net margins, […]